<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 29, 1997
URETHANE TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Nevada 1-11600 33-0126369
- --------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
212 West Taft, Orange, California 92866
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (714) 921-2300
<PAGE> 2
ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S
Urethane Technologies, Inc. (the "Company") sold 1 Convertible
Debenture at a price of $25,000 on January 29, 1997. The Offering was made on
behalf of the Company by Astor Capital as placement agent and was made to
non-U.S. persons (as defined in Regulation S). The Offering raised an aggregate
of $25,000, of which the placement agent received a commission of ten percent.
The Convertible Debenture is convertible into shares of common stock at the
lesser of a certain discount to the bid price of the common stock at the date
of the sale of the Convertible Debenture or a different discount to the bid
price of the common stock at the date of conversion. The Offering was made in
reliance on Regulation S promulgated under the Securities Act of 1933, based
on the fact that the Company is a reporting issuer pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934, the offer and sale of the
Convertible Debenture was made in an offshore transaction (as defined in
Regulation S), and no direct selling efforts were made in the United States by
the Company, a distributor, any of their respective affiliates, or any person
acting on behalf of any of the foregoing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: February 11, 1997 URETHANE TECHNOLOGIES, INC.
By: /s/ JAMES B. FRAKES
-----------------------------
James B. Frakes
Chief Financial Officer
